Another achievement to bring Radiotheranostics forward
300 hospitals registered on the Oncidium foundation Map! Another achievement [...]
NET Patient Testimonial, how PRRT saved Tom’s life
Tom is a composer, pianist, audio producer and neuroendocrine tumor patient. [...]
Diagnostic accuracy of F-18-PSMA-1007-PET/CT imaging for prostate carcinoma
J. Nucl. Me. 2020 Aug 17 18F-PSMA-1007-PET/CT reliably detects malignant [...]
Radiopharmaceuticals Emerging as New Cancer Therapy
National cancer Institute. October 26, 2020 The last years have [...]
October Rose – Breast Cancer Awareness Month
The Oncidium foundation wears the colors of October Rose. Breast [...]
Nuclear Medicine and Molecular Imaging Week: October 4-10, 2020
October 4-10 2020 is nuclear medicine and molecular imaging week! [...]
First clinical results for PSMA TAT using Ac-225-PSMA-I&T in advanced mCRPC patients
First clinical results for PSMA targeted alpha therapy using 225Ac-PSMA-I&T [...]
IAEA activities on Cu-67, Re-186, Sc-47 Theranostic radionuclides and Radiopharmaceuticals
International Atomic Energy Agency (IAEA) activities on 67Cu, 186Re, 47Sc [...]
The Role of Ga-68-FAPI PET/CT for Malignancies of the Lower GI Tract
The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of [...]
First patients dosed in clinical trial of novel lung and ovarian cancer theranostic
Telix Pharmaceuticals Limited announced that the first two patients have [...]